CHANGES OF COLONIC VASOACTIVE-INTESTINAL-PEPTIDE AND CHOLINERGIC ACTIVITY IN RATS WITH CHEMICAL COLITIS

被引:45
作者
KISHIMOTO, S
KOBAYASHI, H
SHIMIZU, S
HARUMA, K
TAMARU, T
KAJIYAMA, G
MIYOSHI, A
机构
[1] Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima, 734, 1-2-3 Kasumin, Minami-ku
关键词
DEXTRAN SULFATE COLITIS; VIP-LIKE IMMUNOREACTIVITY; RAT MODEL; ULCERATIVE COLITIS; IMMUNOCYTOCHEMISTRY; ACETYLCHOLINE ESTERASE; ACETYLCHOLINE;
D O I
10.1007/BF01299867
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The vasoactive intestinal peptide concentration was examined in the colonic wall and portal venous plasma of rats with chemical colitis by radioimmunoassay, and the colonic localization was determined with immunocytochemistry. Colonic acetylcholine esterase activity was also measured, and the response of vasoactive intestinal peptide to acetylcholine administration was determined. Colitis was induced by administration of dextran sulfate for three months. The chemical colitis was histologically similar to active human ulcerative colitis. We observed a significant increase of immunostained neurons and nerve fibers and a significant rise in the colonic wall vasoactive intestinal peptide content in chemical colitis rats, while plasma concentrations of the peptide did not change significantly. Colonic acetylcholine esterase activity was significantly elevated in colitis rats compared with control rats. Systemic administration of acetylcholine significantly increased the colonic and plasma vasoactive intestinal peptide concentrations in colitis rats. These findings demonstrated a positive association between colitis activity and an increase of vasoactive intestinal peptide and suggested that increased vagal tone promoted the peptide's release.
引用
收藏
页码:1729 / 1737
页数:9
相关论文
共 35 条
[1]  
BISHOP AE, 1980, GASTROENTEROLOGY, V79, P853
[2]   DUAL EFFECTS OF VASOACTIVE-INTESTINAL-PEPTIDE (VIP) ON LEUKOCYTE MIGRATION [J].
BONDESSON, L ;
NOROLIND, K ;
LIDEN, S ;
GAFVELIN, G ;
THEODORSSON, E ;
MUTT, V .
ACTA PHYSIOLOGICA SCANDINAVICA, 1991, 141 (04) :477-481
[3]  
BRYANT MG, 1976, LANCET, V1, P991
[4]   RELEASE OF VASOACTIVE INTESTINAL POLYPEPTIDE IN MAST-CELLS BY HISTAMINE LIBERATORS [J].
CUTZ, E ;
CHAN, W ;
TRACK, NS ;
GOTH, A ;
SAID, SI .
NATURE, 1978, 275 (5681) :661-662
[5]  
DOMSCHKE S, 1978, PHARMACOKINETICS PHA, P475
[6]  
DOMSCHKE S, 1982, VASOACTIVE INTESTINA, P201
[7]   VASOACTIVE INTESTINAL PEPTIDE AS A LABORATORY SUPPLEMENT TO CLINICAL ACTIVITY INDEX IN INFLAMMATORY BOWEL-DISEASE [J].
DUFFY, LC ;
ZIELEZNY, MA ;
RIEPENHOFFTALTY, M ;
BYERS, TE ;
MARSHALL, J ;
WEISER, MM ;
GRAHAM, S ;
OGRA, PL .
DIGESTIVE DISEASES AND SCIENCES, 1989, 34 (10) :1528-1535
[8]  
FAHRENKRUG J, 1982, VASOACTIVE INTESTINA, P361
[9]  
FERRI GL, 1983, GASTROENTEROLOGY, V84, P777